Benign Prostatic Hyperplasia

The prostate is a male gland that secretes the fluid (a part of the semen) which carries sperm from the testicles during ejaculation.

The prostate is located just below the bladder and in front of the rectum. It surrounds the first inch of the urethra (the tube through which urine and sperm exit the body).

Usually, the prostate gland starts to enlarge after middle age. When the prostate becomes enlarged, the condition is called benign prostatic hyperplasia (BPH), or benign prostatic hypertrophy.

Description of Benign Prostatic Hyperplasia

The prostate gland undergoes two growth spurts: once during adolescence and the other around the age of 50. Though the prostate continues to grow during most of a man's life, the enlargement does not usually cause problems until late in life. About 75 percent of men over the age of 50 and 90 percent of men in their 70s and 80s have had some symptoms of BPH.

The benign growth occurs when old cells do not die (as they once did) while new cells continue to grow. This accumulation of cells thickens the prostate, which can narrow the urethra, resulting in urination problems.

Causes and Risk Factors of Benign Prostatic Hyperplasia

As the urethra is squeezed more tightly by the enlarged prostate, the bladder may not be able to completely empty. Rarely, this blockage may cause repeated urinary tract infections and start the process of bladder or kidney damage. It may also cause acute urinary retention (a sudden inability to urinate ) which requires a visit to the emergency room.

The cause of BPH is not well understood, but researchers theorize that BPH could be caused by:

Symptoms of Benign Prostatic Hyperplasia

As the urethra becomes narrower, the bladder wall becomes thicker and the bladder itself becomes smaller, causing:

If a man suddenly becomes unable to pass any urine at all, this condition is called acute urinary retention.

The size of the prostate does not always determine how severe the obstruction or the symptoms will be. Some men with greatly enlarged glands have little obstruction and few symptoms, while others whose glands are less enlarged may have more blockage and greater problems.

Diagnosis of Benign Prostatic Hyperplasia

It is possible to have prostate enlargement and prostate cancer at the same time, but it is important to remember that prostate enlargement is not prostate cancer. In addition, having BPH does not seem to increase your chances of developing prostate cancer.

To make a diagnosis, the doctor will first take a detailed medical history to determine the severity of the symptoms. The results of this questionnaire will determine the course of treatment.

Additionally, a physical exam will be performed, including a digital rectal exam (DRE). This procedure involves the doctor inserting a latex-gloved finger into the rectum and feeling the prostate for any lumps or hard spots (that may indicate prostate cancer) and checking the size of the prostate to diagnose BPH.

Based on the results of the DRE and the answers to the questionnaire, the doctor may suggest a urine flow study to measure how quickly the urine is flowing, and a prostate-specific antigen (PSA) blood test. The PSA test is approved by the FDA for the purposes of helping to detect prostate cancer in men over 50 and for monitoring prostate cancer patients after treatment.

Importantly, there are some unknowns about the interpretation of PSA levels, as well as about the test's ability to discriminate cancer from benign prostate conditions and what is the best course of action following a finding of elevated PSA.

If there is a suspicion of prostate cancer, your doctor may recommend a biopsy with rectal ultrasound.

An exam that may be performed to evaluate this problem is a cystoscopy in which a small, thin viewing scope is passed through the urethra into the bladder to look for blockages or other abnormalities of the inside of the prostate. A bladder ultrasound may be used to check for residual urine in the bladder.

It is important to tell the doctor about any urinary problems, such as those described in the SYMPTOMS and SIGNS section. Although these symptoms suggest BPH, they can also signal more serious conditions, such as a bladder infection, bladder stones, prostate cancer, diabetes, multiple sclerosis and Parkinson's disease.

Treatment of Benign Prostatic Hyperplasia

If the score on the Symptom Index is low, the symptoms are considered mild and the usual procedure is "watchful waiting." No pharmaceutical or surgical treatment is recommended. Continue to have an annual exam so that the doctor can monitor the growth. The doctor will suggest the following lifestyle adjustments to ease symptoms:

If the score on the Symptom Index is in the mid-range, symptoms are considered moderate and the usual procedure is pharmaceutical intervention. There are two types of prescription drugs commonly used to treat BPH; alpha-receptor blockers and 5-alpha-reductase inhibitors.

Alpha-receptor blockers (which are also sometimes prescribed for hypertension) relax the prostatic-urethral muscle thereby improving urinary flow. The most common alpha-receptor blockers are Flomax, Uroxatral, Doxazosin and Terazosin.

5-alpha-reductase inhibitors helps shrink the prostate. Finasteride and Avodart are the 5-alpha-reductase inhibitors available. Some physicians, particularly in Europe, recommend the use of (the herb) Saw Palmetto extract to reduce this level of symptoms of BPH.

If the score on the Symptom Index is high, the symptoms are considered severe and the usual procedure is the use of invasive techniques. There are two types of invasive techniques, non-surgical and surgical.

Non-surgical invasive treatments include transurethral microwave thermotherapy (TUMT) and transurethral needle ablation (TUNA).

For the TUMT (Prostatron) procedure, a catheter is threaded through the urethra into the prostate. A computer pulses microwaves through the catheter, heating the prostate, killing prostate tissue to reduce the size of the prostate. This clears room for the urethra to function normally.

A similar device called the Targis System received FDA approval in September 1997. Like the Prostatron, the Targis System delivers microwaves to destroy selected portions of the prostate and uses a cooling system to protect the urethra. A heat-sensing device inserted in the rectum helps monitor the therapy.

Both of these procedures take about 1 hour and can be performed on an outpatient basis without general anesthesia. Neither procedure has been reported to lead to impotence or incontinence. Although microwave therapy does not cure BPH or and does not correct the problem of incomplete emptying of the bladder, it does reduce urinary frequency, urgency, straining, and intermittent flow,

In the TUNA procedure, a pencil-sized treatment wand is inserted into the urethra. Once in place, two small needles (from the tip of the wand) are pushed into the prostate. Radio waves from the needles heat the surrounding tissue, creating zones of dead BPH tissue that the body absorbs. The TUNA System improves urine flow and relieves symptoms with fewer side effects compared to the transurethral resection of the prostate (TURP) (below). No incontinence or impotence has been observed as a result of this procedure.

Surgical treatments include transurethral resection of the prostate (TURP), transurethral incision of the prostate (TUIP), laser prostatectomy and an open prostatectomy. TURP is the gold standard for prostate surgeries performed for BPH.

For a TURP procedure, an instrument called a resectoscope is inserted through the penis. The resectoscope (about 12 inches long and 1/2 inch in diameter) contains a light, valves for controlling irrigating fluid and an electrical loop that cuts tissue and seals blood vessels. During the operation, the surgeon uses the wire loop of the resectoscope to remove the obstructing tissue one piece at a time. The pieces of tissue are carried by fluid into the bladder and then flushed out at the end of the operation.

A variation of TURP is a laser ablation. Laser ablation uses a high-powered laser (instead of a surgical instrument) to vaporize the BPH tissue. The majority of laser surgeries can be performed in an out-patient setting.

Instead of removing tissue (as with TURP) TUIP involves making a few small cuts in the prostate gland. This reduces the pressure on the urethra and permits urine to flow more freely.

A prostatectomy is the removal of the inner portion of the prostate through an open incision in the lower abdomen. This is an invasive surgery reserved for very large prostate glands.

Surgery usually offers relief from BPH for at least 15 years. Surgery for BPH leaves behind a good part of the gland, so it is still possible for prostate problems, including BPH, to develop again. However, only 10 percent of the men who have surgery for BPH eventually need a second operation for enlargement. Usually these men had the first surgery at an early age.

Risks and benefits exist with all forms of treatment for BPH. They are as follows:

TUMT is considered to be less effective than surgery, particularly when obstruction is at the center of the prostate. There is a risk of impotence, incontinence and retrograde ejaculation, where the amount of ejaculate is lessened because most or all of it is retained in the bladder. Though no hospitalization is required with this procedure and relief can be experienced within in three to eight weeks, another TUMT may be necessary at a later date.

TUNA is less effective than surgery. There is the possiblity of impotence, incontinence and retrograde ejaculation. Though no hospitalization is required with this procedure and relief can be experienced within in three to eight weeks, another TUNA may be necessary in the future.

TURP presents a risk of retrograde ejaculation 80 percent of the time. There is the possiblity of impotence, incontinence, blood loss and urinary tract infection. This procedure provides instant relief of BPH and improved urination. One week of recovery time is needed. This is considered to be better than the other treatments.

Laser ablation is less invasive. There is a 20 percent risk of retrograde ejaculation. Some burning with urination may occur. There is virtually no bleeding from the surgery.

TUIP surgery leaves the possibility of impotence, incontinence, blood loss, urinary tract infection and retrograde ejaculation. This procedure provides instant relief of BPH. There is the possiblity of a hospital stay with a short recovery time.

New surgical alternatives are being developed. Ask your doctor to discuss the potential risks and benefits of medication and surgery.

What Questions To Ask Your Doctor About Benign Prostatic Hyperplasia

If treatment is not done now, will there be more serious problems in the future?

Will a change in diet, exercise, coffee or alcohol consumption, etc., make a difference?